Literature DB >> 22904032

Nutritional and global indexes of progression in dementia: a 12-month prospective study.

Alessandra Coin1, Francesco Bolzetta, Marina De Rui, Nicola Veronese, Serena Granziera, Agostino Girardi, Enzo Manzato, Giuseppe Sergi.   

Abstract

BACKGROUND: To assess the influence of body mass index (BMI) on the progression of dementia.
METHODS: Sixty elderly outpatients with untreated dementia followed for 12 months. All patients underwent clinical, cognitive, functional, and nutritional assessment at the baseline and after 12 months. Patients were divided into 2 groups by baseline BMI (< or ≥25 kg/m(2)).
RESULTS: Participants with a baseline BMI ≥25 kg/m(2) had significantly higher Mini-Mental State Examination (MMSE) scores (21 ± 5.1 vs 15.9 ± 5.5; P < .001), while clinical dementia rating (CDR) and multidimensional prognostic index (MPI) scores were similar in the 2 groups. After 12 months, the MMSE score decreased significantly in both groups compared to the baseline, while the CDR and MPI scores increased significantly for patients with a baseline BMI <25 kg/m(2).
CONCLUSION: A BMI cutoff of 25 kg/m(2) could be useful for identifying frail patients with dementia who will experience a more rapid global impairment, which could be assessed adequately using multidimensional evaluation tools.

Entities:  

Mesh:

Year:  2012        PMID: 22904032     DOI: 10.1177/1533317512456451

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  2 in total

Review 1.  A multidimensional approach to frailty in older people.

Authors:  Alberto Pilotto; Carlo Custodero; Stefania Maggi; Maria Cristina Polidori; Nicola Veronese; Luigi Ferrucci
Journal:  Ageing Res Rev       Date:  2020-03-21       Impact factor: 10.895

2.  High levels of plasma fibrinogen are related to post-stroke cognitive impairment.

Authors:  Yuntao Liu; Huijun Chen; Kai Zhao; Weilei He; Shasha Lin; Jincai He
Journal:  Brain Behav       Date:  2019-09-02       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.